Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity

Vaccine
K SuwansrinonV Sitprija

Abstract

Physicians dealing with potential rabies exposures and travel medicine are frequently asked how long previous pre- or post-exposure rabies vaccination induced immunity persists. We therefore carried out a prospective study on 118 rabies vaccine recipients who had received pre- or post-exposure regimens with tissue culture rabies vaccines by intramuscular or intradermal schedules 5-21 years previously. Rabies neutralizing antibody was detectable in the sera of all subjects on day 0. They then received one intradermal 0.1 mL booster injection on days 0 and 3. Neutralizing antibody determination was carried out on days 5, 7 and 14. All except one subject showed an accelerated antibody response following the two booster injections. Vaccination with a WHO recognized tissue culture rabies vaccine evokes long lasting immunity. This study supports current recommendations that immunity is long lasting and that boosters without immunoglobulin are sufficient even when prior vaccination was longer than 5 years previously.

Citations

Feb 25, 2014·Current Infectious Disease Reports·Philippe Gautret, Philippe Parola
Jan 15, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Nguyen Cong VienJean Lang
Apr 11, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·C StradyA Strady
Jul 25, 2012·Current Opinion in Infectious Diseases·Philippe Gautret, Philippe Parola
May 3, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Henry Wilde
Oct 11, 2008·Expert Review of Vaccines·Jean-François Nicolas, Bruno Guy
Jun 26, 2012·Expert Opinion on Biological Therapy·Qin Liu, Hildegund C J Ertl
Feb 22, 2012·Travel Medicine and Infectious Disease·M J Warrell
Nov 17, 2011·Vaccine·Philippe Gautret, Philippe Parola
Apr 17, 2009·Vaccine·B Dodet, UNKNOWN Asian Rabies Expert Bureau (AREB)
Apr 13, 2013·Journal of Travel Medicine·Henry WildeThiravat Hemachudha
Oct 2, 2007·Vaccine·Henry Wilde
Oct 13, 2011·Advances in Preventive Medicine·David BrownMartin Schweiger
Dec 19, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Poh Lian Lim, Timothy M S Barkham
Feb 27, 2016·PLoS Neglected Tropical Diseases·Naseem SalahuddinNaila Baig-Ansari
May 23, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annefleur C LangedijkCornelis Stijnis
Jun 26, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick SoentjensEmmanuel Bottieau
Dec 20, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick SoentjensEmmanuel Bottieau
Dec 6, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Camilla RotheUNKNOWN Ständiger Ausschuss Reisemedizin (StAR) der Deutschen Gesellschaft für Tropenmedizin und Globale Gesundheit (DTG)
Sep 9, 2017·Tropical Diseases, Travel Medicine and Vaccines·Tida K LeeTimothy J Whitman
Jan 1, 2014·Veterinary Record Open
Jan 28, 2021·The Journal of Infectious Diseases·Cornelis A De PijperCornelis Stijnis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.